(Q22010936)

positive regulation of nitric-oxide synthase biosynthetic process

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

J Kroll

Kroll

1 reference

PubMed

PubMed publication ID

10600473

7 February 2023

J Waltenberger

series ordinal

author given names

author last names

Waltenberger

1 reference

PubMed

PubMed publication ID

10600473

Biochemical and Biophysical Research Communications

7 February 2023

language of work or name

English

0 references

publication date

30 November 1999

0 references

published in

0 references

volume

265

0 references

issue

0 references

page(s)

636-9

0 references

cites work

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

Endothelial dysfunction in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021

The biology of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.1729

7 January 2021